A micropillar array-based microfluidic chip for label-free separation of circulating tumor cells: The best micropillar geometry?
Journal of Advanced Research · 2023-05 · 47 · 105-121
DOI: 10.1016/j.jare.2022.08.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Advanced Research, 2023-05. Verfasst von Mehdi Rahmanian und 14 weiteren Autor:innen. Beteiligte Einrichtung: Biomaterials and Tissue Engineering Research Group, Interdisciplinary Technologies Department, Breast Cancer Research Center, Motamed Cancer Institut…. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Breast Neoplasms. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
INTRODUCTION: The information derived from the number and characteristics of circulating tumor cells (CTCs), is crucial to ensure appropriate cancer treatment monitoring. Currently, diverse microfluidic platforms have been developed for isolating CTCs from blood, but it remains a challenge to develop a low-cost, practical, and efficient strategy. OBJECTIVES: This study aimed to isolate CTCs from the blood of cancer patients via introducing a new and efficient micropillar array-based microfluidic chip (MPA-Chip), as well as providing prognostic information and monitoring the treatment efficacy in cancer patients. METHODS: We fabricated a microfluidic chip (MPA-Chip) containing arrays of micropillars with different geometries (lozenge, rectangle, circle, and triangle). We conducted numerical simulations to compare velocity and pressure profiles inside the micropillar arrays. Also, we experimentally evaluated the capture efficiency and purity of the geometries using breast and prostate cancer cell lines as well as a blood sample. Moreover, the device's performance was validated on 12 patients with breast cancer (BC) in different states. RESULTS: The lozenge geometry was selected as the most effective and optimized micropillar design for CTCs isolation, providing high capture efficiency (>85 %), purity (>90 %), and viability (97 %). Furthermore, the lozenge MPA-chip was successfully validated by the detection of CTCs from 12 breast cancer (BC) patients, with non-metastatic (median number of 6 CTCs) and metastatic (median number of 25 CTCs) diseases, showing different prognoses. Also, increasing the chemotherapy period resulted in a decrease in the number of captured CTCs from 23 to 7 for the metastatic patient. The MPA-Chip size was only 0.25 cm2 and the throughput of a single chip was 0.5 ml/h, which can be increased by multiple MPA-Chips in parallel. CONCLUSION: The lozenge MPA-Chip presented a novel micropillar geometry for on-chip CTC isolation, detection, and staining, and in the future, the possibilities can be extended to the culture of the CTCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomaterials and Tissue Engineering Research Group, Interdisciplinary Technologies Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran; Microsystems Research Section, Department of M…
- Biomaterials and Tissue Engineering Research Group, Interdisciplinary Technologies Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.
- Breast Diseases Group, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.
- Microsystems Research Section, Department of Mechanical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.
- Nanotechnology Department, School of Advanced Technologies, Iran University of Science and Technology, Tehran, Iran.
- Laboratory of Immunoengineering, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands; Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhov…
Zitieren
APA
Rahmanian, M., Sartipzadeh Hematabad, O., Askari, E., Shokati, F., Bakhshi, A., Moghadam, S., Olfatbakhsh, A., Al Sadat Hashemi, E., Khorsand Ahmadi, M., Morteza Naghib, S., Sinha, N., Tel, J., Eslami Amirabadi, H., den Toonder, J. M. J., & Majidzadeh-A, K. (2023). A micropillar array-based microfluidic chip for label-free separation of circulating tumor cells: The best micropillar geometry?. Journal of Advanced Research, 47, 105-121. https://doi.org/10.1016/j.jare.2022.08.005
Vancouver
Rahmanian M, Sartipzadeh Hematabad O, Askari E, Shokati F, Bakhshi A, Moghadam S, et al. A micropillar array-based microfluidic chip for label-free separation of circulating tumor cells: The best micropillar geometry?. Journal of Advanced Research. 2023;47:105-121. doi:10.1016/j.jare.2022.08.005
BibTeX
@article{Rahmanian2023,
author = {Rahmanian, Mehdi and Sartipzadeh Hematabad, Omid and Askari, Esfandyar and Shokati, Farhad and Bakhshi, Atin and Moghadam, Shiva and Olfatbakhsh, Asiie and Al Sadat Hashemi, Esmat and Khorsand Ahmadi, Mohammad and Morteza Naghib, Seyed and Sinha, Nidhi and Tel, Jurjen and Eslami Amirabadi, Hossein and den Toonder, Jaap M J and Majidzadeh-A, Keivan},
title = {A micropillar array-based microfluidic chip for label-free separation of circulating tumor cells: The best micropillar geometry?},
journal = {Journal of Advanced Research},
year = {2023},
volume = {47},
pages = {105--121},
doi = {10.1016/j.jare.2022.08.005}
}
EUVIMED